Back to Search
Start Over
Electroanalytical Overview: The Determination of Levodopa (L-DOPA).
- Source :
-
ACS measurement science au [ACS Meas Sci Au] 2023 Feb 03; Vol. 3 (2), pp. 84-97. Date of Electronic Publication: 2023 Feb 03 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- L-DOPA (levodopa) is a therapeutic agent which is the most effective medication for treating Parkinson's disease, but it needs dose optimization, and therefore its analytical determination is required. Laboratory analytical instruments can be routinely used to measure L-DOPA but are not always available in clinical settings and traditional research laboratories, and they also have slow result delivery times and high costs. The use of electroanalytical sensing overcomes these problems providing a highly sensitivity, low-cost, and readily portable solution. Consequently, we overview the electroanalytical determination of L-DOPA reported throughout the literature summarizing the endeavors toward sensing L-DOPA, and we offer insights into future research opportunities.<br />Competing Interests: The authors declare no competing financial interest.<br /> (© 2023 The Authors. Published by American Chemical Society.)
Details
- Language :
- English
- ISSN :
- 2694-250X
- Volume :
- 3
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- ACS measurement science au
- Publication Type :
- Academic Journal
- Accession number :
- 37090256
- Full Text :
- https://doi.org/10.1021/acsmeasuresciau.2c00071